94 research outputs found
Heterogeneus proliferative response of B chronic lymphocityc leukaemia cells to different activation signals and IL-2
No full textno abstrac
Kinetic and immunophenotipic heterogeneity in acute myeloid leukemia subpopulations.
No full textno abstrac
P-GLYCOPROTEIN EXPRESSION IN ACUTE MYELOBLASTIC-LEUKEMIA ANALYZED BY IMMUNOCYTOCHEMISTRY AND FLOW-CYTOMETRY
No full textUsing the APAAP technique, we assessed the reactivity of five monoclonal antibodies, JSB1, C219, Mab 57, 2F8 and MRK16, to gp 170 in 60 cases of de novo acute myeloid leukemia (AML) and 13 relapses. Reactivity, varied between the five antibodies, and positivity was obtained with 2F8 > JSB1 > MRK16 > Mab57 > C219. Sixteen of the 60 cases were also studied by flow cytometry. In 10 cases, the results with the two techniques corresponded, in the other 6 cases, flow cytometry proved more sensitive than APAAP in detecting small amounts of gp170. In the flow cytometry analysis, the cells fixed in methanol and paraformaldehyde were more fluorescent than unfixed samples or those fixed in paraformaldehyde or methanol alone. Our results thus reveal that positivity for gp 170 depends on various factors, including the specificity of the monoclonal antibodies, the techniques used and the preservation of the samples. This suggests the need for a dear standardization of the methods to detect gp170
INCIDENCE OF LYMPHOID MARKERS IN ACUTE MYELOID-LEUKEMIA - ALKALINE PHOSPHATASE-ANTIALKALINE PHOSPHATASE VERSUS IMMUNOFLUORESCENCE
No full textThe aim of the present study was to compare the immunofluorescence technique (IF) with the immunoenzymatic (IE) alkaline phosphatase-antialkaline phosphatase method for the evaluation of the presence of lymphoid antigens (Ag) in 46 cases of acute myeloid leukemia (AML). The first technique allows detection of Ag expressed on the cytoplasmic membrane of living cells, whilst the second shows the presence of intracytoplasmic Ag on fixed cells. In general, the percentages of lymphoid Ag expression on AML cells are relatively low with both IE (15.2%) and IF (17.4%). We found a good correlation between the two methods for CD2 (4/4), CD7 (4/5), CD20 (1/1) and CD4 (2/2). The Ag CD19, CD21 and CD8 were negative in all cases, both with IE and with IF. CD3 (2 cases) and CD22 (1 case) were only evident with IE. CD10 was seen in 1 case with IF, whilst it was found more frequently with IE. For this reason, demonstration of CD10 with IF is more specific for the classification of acute leukemia
The Representativeness of Olea Pollen from Olive Groves and the Late Holocene Landscape Reconstruction in Central Mediterranean
No full textModern pollen spectra are an invaluable reference tool for paleoenvironmental and cultural landscape reconstructions, but the importance of knowing the pollen rain released from orchards remains underexplored. In particular, the role of cultivated trees is in past and current agrarian landscapes has not been fully investigated. Here, we present a pollen analysis of 70 surface soil samples taken from 12 olive groves in Basilicata and Tuscany, two regions of Italy that exemplify this cultivation in the Mediterranean basin. This study was carried out to assess the representativeness of Olea pollen in modern cultivations. Although many variables can influence the amount of pollen observed in soils, it was clear that most of the pollen was deposited below the trees in the olive groves. A rapid decline in the olive pollen percentages (c. 85% on average) was found when comparing samples taken from IN vs. OUT of each grove. The mean percentages of Olea pollen obtained from the archeological sites close to the studied orchards suggest that olive groves were established far from the Roman farmhouses of Tuscany. Further south, in the core of the Mediterranean basin, the cultivation of Olea trees was likely situated ~500–1,000 m from the rural sites in Basilicata, and dated from the Hellenistic to the Medieval period
Effect of aging on cholesterol 7 alpha-hydroxylation in humans
No full textIn order to investigate the alterations of bile acid synthesis in aging, we studied the rates of cholesterol 7 alpha-hydroxylation, the rate-limiting step, in 28 patients of different ages (34-83 years old, 14 below and 14 above the age of 65) of both sexes. Hydroxylation rates were determined by tritium release assay after an intravenous bolus of [7 alpha-3H]cholesterol. Cholesterol 7 alpha-hydroxylation was significantly decreased in the older age group, compared to middle-aged subjects, both in males and females; moreover, a significant inverse correlation between hydroxylation rates and age was found in the whole sample (r = -0.56; P < 0.01) and in females, but not in males. The percent concentration of deoxycholic acid in plasma (determined by gas-liquid chromatography) was increased in older subjects. Plasma cholesterol and triglyceride levels were not related with age even though triglyceride concentrations tended to be lower in the older age group. Triglyceride, but not cholesterol levels, were directly correlated with hydroxylation rates (r = 0.45, P < 0.05). After cholestyramine treatment (8-12 g/day for 4 weeks) a sharp increase in 7 alpha-hydroxylation rates was observed in three elderly patients, accompanied by reduced levels of dihydroxylated bile acids. Our data are consistent with a reduced rate of conversion of cholesterol to bile acids with aging, particularly in females, and suggest a coordinate reduction of triglyceride production. Alterations of the quantitative and/or qualitative pattern of the bile acid pool recirculating to the liver may be responsible, at least in part, for the changes observed
Bcl-2 oncoprotein expression in acute myeloid leukemia
No full textBACKGROUND. In lymphoproliferative diseases the expression of Bcl-2, a mitochondrial oncoprotein capable of blocking apoptosis, is well-documented, while little research has been carried out on its distribution in myeloproliferative conditions. METHODS. Using immunocytochemical methods, 63 cases of acute myeloid leukemia (AML) at onset and 10 relapses were studied to investigate Bcl-2 expression and any possible correlations with subtypes of the FAB classification, sex, age or white cell peripheral blood count at onset. RESULTS. Bcl-2 is present in 87.3% of AML cases at onset and in 100% of relapses. In 68.3% of cases at onset and in 90% of relapses the protein is present in more than 20% of the blasts. Relapses always show higher percentages of positive expression than those seen at onset. Our results demonstrate no statistical correlations between the expression of the oncoprotein Bcl-2 and FAB subtypes, sex, age, or white cell peripheral blood count. CONCLUSIONS. The majority of blasts from AML patients express the oncoprotein Bcl-2, which is able to protect leukemic cells from apoptosis. Since numerous chemotherapies are cytotoxic in that they induce apoptosis, we feel that in vitro studies of cells from AML patients are necessary in order to broaden our knowledge about the effects of the most common therapeutic drugs and of those substances which, alone or in association, can modulate Bcl-2 expression
- …
